web page,US Brand Names
Alemtuzumab is a monoclonal antibody. It is used to treat a certain type of leukemia called B-cell chronic lymphocytic leukemia (B-CLL). It is given to recently diagnosed patients and to patients whose disease has progressed despite treatment with other cancer medicines. Alemtuzumab interferes with the growth of leukemic cells, which are then destroyed by the body .